Abstract
In order to elucidate the postoperative changes in hemostasis, three molecular markers; fibrinopeptide A (FPA), fibrinopeptide Bβ15-42 (Bβ15-42) and D-dimer, were serially determined in 27 gastric resections (group A), 27 hepatic resections (group B) and 4 probe laparotomies (group C). Unexpectedly, a postoperative hypercoagulable state was transient and of a low magnitude, as determined by the obtained value of FPA. On the other hand, a significant fibrinolysis (an elevation of Bβ15-42) was observed immediately after surgery which continued for over 10 days. The early phase of fibrinolysis, up until the 3rd postoperative day, is likely to be primary fibrinolysis, as it was not accompanied by the formation of D-dimer, which results from the digestion of fibrin by plasmin. The late phase, however, is considered to be secondary fibrinolysis, as D-dimer was elevated during this phase. Despite the different surgical procedures, these changes were basically similar between the patients who underwent gastric resections and those who underwent liver resections. The postoperative changes in hemostasis as presented herein may therefore be the general physiological response, at least against abdominal surgery.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Mansfield AO. Alteration in fibrinolysis associated with surgery and venous thrombosis. Br J Surg 1972; 59: 754–775.
Reilly DT, Burden AC, Fossard DP. Fibrinolysis and the prediction of postoperative deep vein thrombosis. Br J Surg 1980; 67: 66–68.
Kruse-Blinkenberg HO, Gormsen J. The influence of low dose heparin in elective surgery on blood coagulation. Fibrinolysis, platelet function, antithrombin and antiplasmin. Acta Chir Scand 1980; 146: 376–382.
Collins JA. Massive blood transfusion. Clin Haematol 1976; 5: 201–222.
Counts RB, Haisch C, Simon TL, Maxwell NG, Heimbach DM, Carrico CJ. Hemostasis in massively transfused trauma patients. Ann Surg 1979; 190: 91–99.
Nossel HL, Younger LR, Wilner GD, Procupez T, Canfield RE, Butler Jr VP. Radioimmunoassay of human fibrinopeptide A. Proc Natl Acad Sci 1971; 68: 2350–2353.
Nossel HL, Yudelman I, Canfield RE, Butler Jr VP, Spanondis K, Wilner GD, Qureshi GD. Measurement of fibrinopeptide A in human blood. J Clin Invest 1974; 54: 43–53.
Kudryk B, Robinson D, Netre C, Hessel B, Blömback B. Measurement in human blood of fibrinogen/fibrin fragments containing the Bβ15-42 sequence. Thrombos Res 1982; 25: 277–291.
Hurlet-Jensen A, Koehn JA, Nossel HA. The release of Bβ15-42 from fibrinogen and fibrin by plasmin. Thrombos Res 1983; 29: 609–617.
Kang JH, Kambayashi J, Sakon M, Shiozaki H, Ogawa Y, Ohshiro T, Mori T. Mechanism of the haemostatic effect of ethanolamine oleate in the injection sclerotherapy for oesophageal varices. Br J Surg 1987; 74: 50–53.
Lane DA, Ireland H, Wolff S, Grant R, Jennings S, Allen-Mersh T. Plasma concentrations of fibrinopeptide A, fibrinogen fragment Bβ15-42 and β-thromboglobulin following total hip replacement. Thrombos Res 1982; 26: 111–118.
Douglas JT, Blamey SL, Lowe GDO, Carter DC, Forbes CD. Plasma beta-thromboglobulin, fibrinopeptide A and Bβ15-42 antigen in relation to postoperative DVT, malignancy and stanozolol treatment. Thrombos Haemostas 1985; 53: 235–238.
Budzynski AZ, Marder MJ, Parker ME, Shames P, Brizuela BS, Olexa SA. Antigenic markers on fragment DD: A unique plasmic derivative of human crosslinked fibrin. Blood 1979; 54: 794–804.
Vihko P, Kostama A, Sajanti E, Vihko R. Rapid radioimmunoassay for prostate-specific acid phosphatase in human serum. Clin Chem 1980; 26: 1544–1547.
Greenwood FC, Hunter WM, Glover JS. The preparation of131I-labelled human growth hormone of high specific radioactivity. Biochem J 1963; 89: 114–123.
Elms MJ, Bunce FIH, Bundesen PG, Rylatt DB, Webber AJ, Masci PP, Whitaker AN. Rapid detection of cross-linked fibrin degradation products in plasma using monoclonal antibody coated latex particles. Am J Clin Pathol 1986; 85: 360–364.
Colman RW, Marder VJ, Salzman EW, Hirsh J. Overview of haemostasis. In: Colman RW, Hirsh J, Marder VJ, Salzman EW, ed. Haemostasis and thrombosis: Basic principles and clinical practice. Philadelphia: J.B Lippincott. 1987: 3–17.
Weksler BB. Platelet interactions with the blood vessel wall. In: Colman RW, Hirsh J, Marder VJ, Salzman EW, eds. Hemostasis and thrombosis: Basic principles and clinical practice. Philadelphia: J.B Lippincott. 1987: 804–815.
Stead N, Kaplan AP, Rosenberg RD. Inhibition of activated factor XII by antithrombin-heparin cofactor. J Biol Chem 1976; 251: 6481–6488.
McConnell DJ. Inhibition of kallikrein in human plasma. J Clin Invest 1974; 51: 1611–1623.
Seyfer AE, Seaber AV, Dombrose FA, Urbaniac JR. Coagulation changes in elective surgery and trauma. Ann Surg 1981; 193: 210–213.
Collen D, Verstreate M.α 2-antiplasmin consumption and fibrinogen breakdown during thrombolytic therapy. Thrombos Res 1979; 14: 631–639.
Markwardt F, Klocking HP. Studies on the release of plasminogen activator. Thrombos Res 1976; 8: 217–223.
Barker JL, Crayton W, Nicoll RA. Supraoptic neurosecretory cells; adrenergic and cholinergic sensitivity. Science 1972; 71: 208–210.
Astrup T. Fibrinolysis—An overviewing. In: Davidson JF, Rowan RM, Samama MM, Desnoyers PC, eds. Progress in chemical fibrinolysis and thrombolysis. New York: Ravan Press. 1978: 1–57.
Reich E. Plasminogen activator; secretion by neoplastic cells and macrophages. In: Reich E, Rifken DB, Shaw E, eds. Proteases and biological control. Cold Spring: Halor Laboratory. 1975: 333–334.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kang, J., Kambayashi, J., Sakon, M. et al. Postoperative changes in hemostasis analyzed by the serial determination of fibrinopeptides and D-dimer. The Japanese Journal of Surgery 19, 262–268 (1989). https://doi.org/10.1007/BF02471400
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02471400